Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
about
Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression.Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlasTrends in the Mortality of Hepatocellular Carcinoma in the United States.Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: a nationwide cohort study.Cabozantinib in the treatment of hepatocellular carcinoma.Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.Implication of the Hedgehog pathway in hepatocellular carcinoma.Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B.Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach.Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.Preoperative optimization for major hepatic resection.Treatment at a high-volume centre is associated with improved survival among patients with non-metastatic hepatocellular carcinoma.Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas.Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).Transforming growth factor-β in liver cancer stem cells and regeneration.Right Atrium Invasion of Tumor Thrombus from Hepatocellular Carcinoma Incidentally Found on Transthoracic Echocardiogram.Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice.A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.Isoviolanthin Extracted from Dendrobium officinale Reverses TGF-β1-Mediated Epithelial⁻Mesenchymal Transition in Hepatocellular Carcinoma Cells via Deactivating the TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways.Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challengesCarcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancerBiomarkers for hepatocellular carcinoma: What's new on the horizon?Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitusHigh expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazineTrends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysismiR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
P2860
Q33913172-FAB7E185-97AB-4F72-BC1E-8A5109046214Q36327564-54400F21-3E5A-400E-B706-1DA4AECA7F9BQ38635553-627D2318-91F7-487A-ABB0-79B6C19A296CQ38657409-83419DFA-5CD7-480B-B7B0-97ACD6002650Q38658285-D1006613-574D-45D9-B1B5-877C6696A674Q38702281-F8818563-50BE-4F4A-BB83-26F367F5C899Q39433923-5E59E8CF-C16A-4C51-B588-7A7C9B4E7B75Q39458547-20BA54EE-3124-440C-94EE-125519AA58D9Q40054265-6CA900B9-8ECA-4811-8757-6F793AA831B3Q40173544-F59B95F3-354F-41A5-A417-1ACB00FB3E78Q41921861-AA7424E3-59AC-4D56-914E-A8A9E6FF1B0EQ41926688-F0840359-8F33-430B-940B-66E43F40FAE3Q41991379-E19F118E-028E-48EA-8F02-B7A5BED95B36Q42349921-E2319AF4-ABC7-4C46-8B3E-AAB37EDC4102Q47103200-4BB2B356-0591-4335-AD17-B62A833EC426Q47389889-019DFA02-E34A-4E78-B7DF-F9B5D7418912Q48156632-DB2FAABE-6CF8-4D33-9413-1E6F6C4CC81AQ48524250-4E53D041-FFCF-45A9-AB12-DDE44FA54A6BQ49787968-610C044D-C29A-491A-8D92-52F8DD6634C1Q52699075-45DE54BF-DA6F-4315-9FD2-DDCE5BFD36ADQ55008115-FBFACB6C-560F-428F-821A-A35D1E487FBCQ55541749-AE85C316-A278-435A-8A8C-AB4DB8F16287Q55562058-DEBD9901-111B-4BBA-8116-5AAE2047590FQ55625598-AED49A42-0D45-405A-A06E-18974B26B0B1Q55715098-B8CEE775-A2A1-49EE-943C-D6187D2492B2Q57162382-F028BA5C-C433-4816-AADA-CF56038C481BQ57807125-D19B8A07-68FF-4943-BBA5-73D6401B2A9BQ58707823-D23E169F-E0F7-4943-89D6-2716482ED20BQ58739563-93432F9B-D38A-47B9-8564-3EE13BD949FFQ58772807-A4D5B57F-EDD8-4B1A-A712-EF72E3182703Q58777786-7448AD33-D81F-44B1-91B7-3090E6B2F62AQ58784090-BA2E1100-7A20-4136-A7EC-1A840FEDE6D3
P2860
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
@en
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
@nl
type
label
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
@en
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
@nl
prefLabel
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
@en
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
@nl
P2093
P2860
P1433
P1476
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
@en
P2093
Aaron P Thrift
Donna L White
Fasiha Kanwal
Hashem B El-Serag
Jessica Davila
P2860
P304
812-820.e5
P356
10.1053/J.GASTRO.2016.11.020
P407
P577
2016-11-23T00:00:00Z